P1 cultured virus from a monkey pox positive patient.
First Dutch isolate from MPXV infected patient.
NOTE: This material is not available for commercial purposes, such as contract research services”
Tick-borne encephalitis virus (TBEV), subtype TBEV-Eu, divergent strain Salland (the Netherlands) rescued and cultured on BHK-21 cells as described in Hoornweg et al., Sci Rep. 2023 Feb 18;13(1):2872.
Infectious cell culture supernatant containing SARS-CoV-2 (hCoV-19/Netherlands/NH-RIVM-72291/2021, omicron variant). This strain is preserved in viral storage medium -80°C.
Infectious cell culture supernatant containing SARS-CoV-2 (hCoV-19/Netherlands/NH-RIVM-71076/2021, omicron variant). This strain is preserved in viral storage medium -80°C.
Infectious cell culture supernatant containing SARS-CoV-2 (hCoV-19/Netherlands/NH-RIVM-27142/2021, Delta variant). This strain is preserved in viral storage medium -80°C.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant